The content on this site is intended for healthcare professionals only
Prof Martin Gore and Prof Gordon McVie sit down at the National Cancer Research Institutes cancer conference in Liverpool, UK to discuss the prevention of toxicity and side effects during treatment. The management of all therapies and side effects is essential to long term care of patients, but the most important element of prevention is patient education.
Education is the common thread for preparative and preventative treatment to ensure that patients have the required knowledge to take decisions and improve their quality of life.
Addressing the rise of multiple myeloma in Rwanda
The combination of regorafenib, nivolumab and SCRT shows promising efficacy as neoadjuvant therapy for locally advanced RC
GIST tumours and soft tissue sarcomas
Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lymphoma
ASCO 2024: Lung cancer highlights
Best practice in HRRm testing in patients with metastatic prostate cancer
Multiple myeloma in a resource constrained setting
Next-generation selective RET inhibitor shows initial promise with RET-altered solid tumours
Systemic anti-cancer performance matrix
